This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Ottawa directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $149,986
Improving prescribing of medications at the end-of-life in long-term care homes through the COVID-19 pandemic
CIHR · 2020 · Principal investigator
- $100,000
Effects of dexmedetomidine in patients with agitated delirium in palliative care: an open-label phase 1/2 proof-of-concept, feasibility, and dose-finding clinical trial
CIHR · 2020 · Co-investigator
Improving prescribing of medications at the end-of-life in long-term care homes through the COVID-19 pandemic
Principal investigators: Tanuseputro, Peter; Arya, Amit; Aynharan, Sinnarajah; Hsu, Amy T; Isenberg, Sarina R; Presseau, Justin; Simon, Jessica E
Keywords: Covid-19; Long-Term Care; Pandemic
Effects of dexmedetomidine in patients with agitated delirium in palliative care: an open-label phase 1/2 proof-of-concept, feasibility, and dose-finding clinical trial
Principal investigators: Downar, James; Kanji, Salmaan; Lascelle, Debi; Lawlor, Peter G; Parsons, Henrique A
Keywords: Agitated Delirium; Dexmedetomidine; Palliative Care; Phase I/Ii Clinical Trial; Qualitative Investigation; Rousable Sedation
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.